3,8-diaminotetrahydroquinoline derivative
AssigneeZeria Pharmaceutical Co., Ltd.
InventorsTakeshi Watanabe, Masaru Terauchi, Masaaki Nagasawa, Kouichirou Tanaka, Masataka Washiduka
Life of this patent
Estimating the term…
Loading patent…
AssigneeZeria Pharmaceutical Co., Ltd.
InventorsTakeshi Watanabe, Masaru Terauchi, Masaaki Nagasawa, Kouichirou Tanaka, Masataka Washiduka
Estimating the term…
To provide a compound which has a potent agonistic activity on GHS-R and which is useful as a therapeutic agent for systemic wasting diseases such as cachexia. A 3,8-diaminotetrahydroquinoline derivative represented by formula (1a) (wherein X represents CH2, C═O, CH—OR, CH—SR, or CH—NRR′; m is a number of 1 or 2; Ar represents a phenyl group, a naphthyl group, a 5-membered or 6-membered aromatic heterocyclic group having one or two elements selected from S, N, and O, or a similar group; R1 and R2, which may be identical to or different from each other, each represent a hydrogen atom or a methyl group; R3 represents a C1 to C6 alkyl group or a similar group; n is a number of 0 or 1; R4 and R5, which may be identical to or different from each other, each represent a hydrogen atom, or a C1 to C6 alkyl group, etc.; and R6, R7, R, and R′, which may be identical to or different from one another, each represent a hydrogen atom or a C1 to C6 alkyl group), or a salt thereof.
A 3,8-diaminotetrahydroquinoline derivative represented by formula (1a):
Dependencies are inferred from the claim text.